Urinary mRNA in systemic lupus erythematosus.
Systemic lupus erythematosus (SLE) is a relapsing autoimmune disease with clinical manifestations that affect multiple organ systems. Lupus nephritis is recognized as one of the most severe organ involvements in SLE and affects half of the lupus patients. Notably, lupus nephritis is characterized by intrarenal lymphocyte activation and inflammation. Since most of the cytokines exert their effects in a paracrine fashion, measuring their expression at the site of pathology should be of biological relevance. Although kidney biopsy is widely used to determine the histology and severity of lupus nephritis, this invasive procedure has its own risk and is not practical for serial monitoring. In the past decade, extraction and quantification of messenger RNA (mRNA) from urinary sediment has emerged as a robust laboratory technique. Quantification of mRNA expression in urinary sediment has been tested as a noninvasive means to assess the disease activity of SLE patients. Available published evidence, however, is limited to small-scale studies. Based on the result of these studies, a number of cytokine and transcript factor genes have been found to have potential for the differentiation between active and inactive SLE, between proliferative and membranous types of lupus nephritis, assessment of the systemic lupus activity or histological activity of kidney biopsy specimen, monitoring of treatment response in active lupus nephritis, or detection of lupus disease flare in clinically quiescent patients. Being a simple and noninvasive method, urinary mRNA level deserves further studies to validate its role in risk stratification and monitoring of therapeutic response in patients with lupus nephritis.
Cheuk-Chun
CC
Szeto
Bonnie Ching-Ha
BC
Kwan
Lai-Shan
LS
Tam
D015415:Biomarkers / Q000652:urine; D016207:Cytokines / Q000235:genetics / Q000652:urine*; D015870:Gene Expression; D020869:Gene Expression Profiling; D006801:Humans; D007668:Kidney / Q000378:metabolism / Q000473:pathology; D008181:Lupus Nephritis / Q000175:diagnosis* / Q000473:pathology / Q000652:urine; D035683:MicroRNAs / Q000235:genetics / Q000652:urine*; D008853:Microscopy; D012333:RNA, Messenger / Q000235:genetics / Q000652:urine*; D012307:Risk Factors; D014157:Transcription Factors / Q000235:genetics / Q000652:urine*; D016482:Urinalysis
D015415:Biomarkers; D016207:Cytokines; D035683:MicroRNAs; D012333:RNA, Messenger; D014157:Transcription Factors